% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • blackmenrock Nov 9, 2012 5:07 PM Flag

    SGEN conference call highlights - 3Q 2012

    I did not know of the sgn40 study. Thank you. I will look at that. I expected 40 to resurface as sgn45 as the naked antibody, like the 30, did not seem to have much anti-tumor activity. With SGEN's new linker and chemo 40 (or 45) could emerge as an excellent candidate in B-cell. Maybe better than the Roche 22 or 79. Let's hope.

45.36+0.06(+0.13%)Aug 29 4:00 PMEDT